Juul Labs Inc. said it will continue to sell its vaping products, which are at the center of an ongoing standoff with the U.S. Food and Drug Administration.

The agency banned Juul's products on June 23, citing a lack of evidence of the company's products' overall safety and noting their disproportionate role in the rise in teen vaping.

The next day, Juul won an emergency court order that temporarily blocked the FDA's decision. In a separate action, the FDA administratively suspended the ban on Tuesday, allowing the company to continue selling its products after it determined there were other scientific issues that needed to be reviewed.

"While we pursue the agency's internal review process, we continue to offer our products to adult smokers," Joe Murillo, Juul's chief regulatory officer, said in an email. "We remain confident in the quality and substance of our application and believe that ultimately we will be able to demonstrate that our product does meet statutory standards to protect public health.

Late Wednesday, both parties asked the court case to be put on hold while the FDA conducts an administrative review.

An FDA spokeswoman said the company still lacks authorization to market, sell or ship its products. During the administrative stay, the agency does not intend to take enforcement action against products subject to marketing denial orders, filings show.

Shares in Marlboro cigarette maker Altria, which bought a 35 percent stake in Juul for $12.8 billion in 2018, were down 1.3 percent at the close in New York.

Prev : American Convenience and Retail Association supports JUUL

Next : Cambodia Vape News

Email:sales@mlifevapor.com

WhatsApp:+86 13871529372

Email:sales@mlifevapor.com

WhatsApp:+86 13871529372

Tel：+86 13871529372

Add：6 / F, block B, building 2, Fuyong Tongtai times center, Bao'an District, Shenzhen

Language：简体中文 | >

Tel：+86 13871529372

Add：6 / F, block B, building 2, Fuyong Tongtai times center, Bao'an District, Shenzhen Website